Prescription Drugs
Filters
Qilu (Osimertinib) 80mg*30 | Qilu China Generic | GLT
Qilu Pharmaceutical (Hainan) — bioequivalent osimertinib 80mg generic for NSCLC
Ninlaro (Ixazomib) 2.3mg/3mg/4mg Capsules | Oral Proteasome Inhibitor | Takeda Japan | GLT
Takeda's first-in-class oral proteasome inhibitor for multiple myeloma, used with lenalidomide and dexamethasone.
PHOIXAZ (Ixazomib) 4mg | Generic Proteasome Inhibitor | Pharma 2 Vientiane | GLT
Generic ixazomib (oral proteasome inhibitor) by Pharma 2 Vientiane (Laos) — an affordable alternative to...
Ninlaro (Ixazomib) 3mg/4mg Capsules | China-Sourced | Oral Proteasome Inhibitor | GLT
Takeda's first-in-class oral proteasome inhibitor for multiple myeloma — NMPA-approved and nationally reimbursed in China,...
Isadx (Ixazomib) 4mg | Generic Proteasome Inhibitor | BigBear Pharmaceutical Co., Ltd. | GLT
Generic ixazomib (oral proteasome inhibitor) by BigBear Pharmaceutical Co., Ltd. (Laos) — an affordable alternative...
Lorlatinib (PHOLORLA) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorbrena) 100mg Tablets | US FDA-Approved ALK Inhibitor for NSCLC | GLT
Pfizer's third-generation brain-penetrant ALK/ROS1 inhibitor for ALK-positive metastatic NSCLC.
Lorlatinib (Lorbrena) 25mg & 100mg Tablets | China NMPA-Approved ALK Inhibitor for NSCLC | GLT
Pfizer's third-generation brain-penetrant ALK/ROS1 inhibitor for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorbrexen) 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (LuciLorla) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
RINVOQ (Upadacitinib) 15mg/30mg Tablets | China-Sourced | JAK1 Inhibitor | GLT
AbbVie's selective JAK1 inhibitor for rheumatoid arthritis, atopic dermatitis and more — NMPA-approved and reimbursed...
Lorlatinib (Lorlatini) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lornatib) 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
Lorlatinib (Lorladx) 25mg & 100mg Tablets | ALK/ROS1 Inhibitor Generic | GLT
Generic lorlatinib for ALK-positive NSCLC, including brain metastases.
LuciUpa (Upadacitinib) 15mg | Generic JAK1 Inhibitor | Lucius Pharmaceuticals (Lao) Co., Ltd. | GLT
Generic upadacitinib (selective JAK1 inhibitor) by Lucius Pharmaceuticals (Lao) Co., Ltd. (Laos) — an affordable...
Olumiant (Baricitinib) 2mg Tablets | China-Sourced | JAK1/JAK2 Inhibitor | GLT
Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and alopecia areata — NMPA-approved...
Upadx (Upadacitinib) 15mg | Generic JAK1 Inhibitor | BigBear Pharmaceutical Co., Ltd. | GLT
Generic upadacitinib (selective JAK1 inhibitor) by BigBear Pharmaceutical Co., Ltd. (Laos) — an affordable alternative...
Upanib (Upadacitinib) 15mg | Generic JAK1 Inhibitor | Ziska Pharmaceuticals Ltd. | GLT
Generic upadacitinib (selective JAK1 inhibitor) by Ziska Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to...
REMATIB (Upadacitinib) 15mg | Generic JAK1 Inhibitor | Drug International Limited | GLT
Generic upadacitinib (selective JAK1 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to...
Barudx (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | BigBear Pharmaceutical Co., Ltd. | GLT
Generic baricitinib (JAK1/JAK2 inhibitor) by BigBear Pharmaceutical Co., Ltd. (Laos) — an affordable alternative to...
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling